Heart failure is a very common clinical condition, afflicting millions of patients worldwide, and its prevalence is expected to further increase in the near future. Unfortunately, there are limited treatment options for advanced heart failure and the overall prognosis remains poor. Show More Summary
A mother who beat cervical cancer twice, including once while pregnant, died of heart failure one day after giving birth to twins. Jamie Snider, of Fresno, California, gave birth to twins Camila and Nico on March 16. During the pregnancy,...Show More Summary
Just a day after delivering twins, a 30-year-old California woman Jamie Snider, who defied cancer during pregnancy, died of heart failure. Snider’s family and friends are now raising funds for well-being of the newborn. “God decidedShow More Summary
A California mom, who beat cancer while pregnant, died of congenital heart failure just one day after delivering her twin babies.
In this article, learn about the most common rhythm disorder of the heart, including how to reduce the risk of stroke and heart failure.
ZURICH (Reuters) - Novartis's heart failure drug serelaxin flopped in a late-stage trial by not cutting cardiovascular death or slowing disease progression, marking the likely demise of a drug hopeful the Swiss firm had promoted as a potential blockbuster.
(Wiley) In the largest German survey on heart failure to date, investigators found that the overall awareness of heart failure has not increased over the past decade and is not at a satisfactory level.
Billionaire philanthropist David Rockefeller, a former head of Chase Manhattan bank and a luminary in political circles, died Monday at the age of 101, a spokesman said. He died in his sleep due to congestive heart failure at his home in Pocantico Hills, just north of New York City, spokesman Fraser Seitel said. Show More Summary
Billionaire David Rockefeller is dead at age 101 of congestive heart failure, according to Inquisitr‘s reports. This event, sad for some and joyous for others, has reignited old debates on this man’s purpose and effect on the world.Show More Summary
At 101, how did David Rockefeller die? The cause of death was congestive heart failure. On Monday, he relinquished the title of world’s oldest billionaire. Rockefeller foundation statement says David Rockefeller’s cause of death at age 101 is congestive heart failure. Show More Summary
Patients with atrial fibrillation (AFib) who are given digoxin to control their symptoms have an increased risk of death, whether or not they have a diagnosis of heart failure, compared with patients not taking the drug, and this risk increases with higher levels of digoxin in the bloodstream, according to new research.
(American College of Cardiology) When used as a preventive measure during heart surgery, the heart failure drug levosimendan did not significantly reduce rates of death, heart attack, kidney dialysis or use of a mechanical assist device...Show More Summary
(American College of Cardiology) Patients with atrial fibrillation (AFib) who are given digoxin to control their symptoms have an increased risk of death, whether or not they have a diagnosis of heart failure, compared with patientsShow More Summary
This just showed up on my timeline. There is no base so solid as rock bottom. ???? ? I am happy that I quit, with whole my heart. Let’s see what the future brings. xx, Feeling I … Continue reading ?
WASHINGTON (Reuters) - A newer class of type 2 diabetes drugs significantly cut the risk of death and hospitalization for heart failure compared with other medicines for the disease, according to data released on Sunday from a so-called real world study sponsored by AstraZeneca.
Those who dieted and exercised lost less weight and had a higher risk of heart failure.
New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk.
(Intermountain Medical Center) New research suggests that GlycA, a newly identified blood marker, and C-reactive protein both independently predict major adverse cardiac events, including heart failure and death. Patients who have high levels of both biomarkers are at especially high risk.
New research examines the role of a type of white blood cells called eosinophils on heart inflammation, dilated cardiomyopathy, and heart failure in mice.
(Johns Hopkins Medicine) A new study in mice reveals that eosinophils, a type of disease-fighting white blood cell, appear to be at least partly responsible for the progression of heart muscle inflammation to heart failure in mice.